Amar Abderrahmani

4.7k citations
78 papers · 3.5k indexed · 1 hit paper · h-index 30
Topics
Pancreatic function and diabetes (43 papers)Diabetes and associated disorders (13 papers)Endoplasmic Reticulum Stress and Disease (10 papers)
Partner nations
FranceSwitzerlandBelgium

In The Last Decade

Amar Abderrahmani

77 papers receiving 3.4k citations

Hit Papers

Inhibition of the glucose transporter SGLT2 with dapaglif...20152026201820222015100200300400500

Peers

Amar Abderrahmani
Comparison fields: 5 of 117
  • Molecular Biology 1.7k
  • Surgery 1.5k
  • Endocrinology, Diabetes and Metabolism 962
  • Cancer Research 814
  • Genetics 627
Replace Kerry S. Russell with:
Kerry S. Russell United States
Ibrahim F. Benter Kuwait
Xia Cao China
Guoqiang Jiang China
Ryan E. Temel United States
Lei Ding China
Jae‐Ryong Kim South Korea
Loredana Mauro Italy
Ebbe Boedtkjer Denmark
Tetsuro Kôno United States
Amar Abderrahmani relative to Kerry S. Russell United States Kerry S. Russell's profile →
Citations per field
00.5×5.2×
Kerry S. Russell · 1×
Citations per year

Countries citing papers authored by Amar Abderrahmani

Since Specialization
Citations

This map shows the geographic impact of Amar Abderrahmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amar Abderrahmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amar Abderrahmani more than expected).

Fields of papers citing papers by Amar Abderrahmani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amar Abderrahmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amar Abderrahmani. The network helps show where Amar Abderrahmani may publish in the future.

Co-authorship network of co-authors of Amar Abderrahmani

This figure shows the co-authorship network connecting the top 25 collaborators of Amar Abderrahmani. A scholar is included among the top collaborators of Amar Abderrahmani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amar Abderrahmani. Amar Abderrahmani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 10
4 16
5 15
6 3
7 8
8 36
9 37
10 17
11 74
12 65
13
Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretionbreakdown →
538
14 14
15 30
16 34
17 127
18 59
19 38
20 9

About Amar Abderrahmani

Amar Abderrahmani is a scholar working on Pharmaceutical Science, Endocrinology, Diabetes and Metabolism and Surgery, having authored 78 papers that have together received 3.5k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (43 papers), Diabetes and associated disorders (13 papers) and Endoplasmic Reticulum Stress and Disease (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (962 citations), Cancer Research (814 citations) and Surgery (1.5k citations). Amar Abderrahmani has collaborated with scholars based in France, Switzerland and Belgium. Frequent co-authors include Romano Regazzi, Gérard Waeber, Valérie Plaisance, Christian Widmann, Sonia Gattesco, E. Roggli, Guy Niederhäuser, Gurvan Quéniat, François Pattou and Valéry Gmyr. Their work appears in journals such as Chemical Society Reviews, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026